PER percheron therapeutics limited

Ann: Update on Partnering Progress, page-5

  1. 8,291 Posts.
    lightbulb Created with Sketch. 787
    Obviously timed to see off Gennadi (stockbroker) / Moses (Mark Diamond days) /Peters (seems like a nice bloke) , but if passion & drive mean anything Garner (Bio-tech professional) certainly has it

    My understanding is that the vote had already landed Garner's way, but PVL (strong backers of Garner) buying another 3% , along with this news flow is designed to make sure no other challengers bother trying again.

    1.4/1.5 is obvious resistance. LOG chart channel resistance. And is cash backing (including tax refund). PER should break above this , but probably not til the vote and we see the details of the new drug indication.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $71.80K 7.180M

Buyers (Bids)

No. Vol. Price($)
1 4649246 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 2600000 2
View Market Depth
Last trade - 15.21pm 13/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.